Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 Adjunctive Therapy in Refractory Partial Seizures (Dose-Escalation, Double-Blind, Placebo-Controlled)
2005-004199-18Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2006
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in focal-onset epileptic seizures and epilepsy comparing E2007 (perampanel) adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoints: Maximum tolerated dose of E2007 as adjunctive therapy, Overall safety of E2007 and 1 more. Started Feb 2006; status: completed.
02
Drugs
perampanel
03
Conditions
focal-onset epileptic seizuresepilepsy
Beyond the preview
Go deeper on 2005-004199-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004199-18.